Agile Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Agile Therapeutics (AGRX) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Agile Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Agile Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Agile Therapeutics by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $15k | 7.7k | 1.95 |
| 2023-09-30 | $8.4k | 3.5k | 2.41 |
| 2023-06-30 | $15 | 5 | 3.00 |